| 网站首页 | 眼科中心 | 协和眼科 | 会议中心 | 医学资源 | 精美图片 | 论坛 | 会员中心 | 帮助中心 | 换眼科点 | 申请权限 | 全站搜索 | 博客 | 手术视频 | 眼科淘宝 | 
最新公告:

  没有公告

您现在的位置: 心灵之窗-眼科医生网 >> 会议中心 >> 第11届全国会 >> 眼底病11 >> 正文
专题栏目
更多内容
相关文章
更多内容
Topoisomerase II inhibitors for proliferative vitreoretinopathy         
Topoisomerase II inhibitors for proliferative vitreoretinopathy
作者:HSI-KUNG… 文章来源:1Department of Ophthalmology, Chang-Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan 2Tissue Culture Center, New York Eye and Ear Infirmary, New York Medical College, New York, USA 点击数:7118 更新时间:2006/7/11 23:11:06
Purpose: The aim of this study was to compare the effect of some commercially available topoisomerase II inhibitors on the proliferation of retinal pigment epithelium (RPE) cells in vitro and test the toxicity and efficacy against experimental proliferative vitreoretinopathy (PVR). Methods: Study medications included etoposide, doxorubicin, and daunorubicin. Rabbit RPE cells were seeded without (control) or with the drugs at various medicine concentrations (100, 30, 10, 1.0, 0.1, 0.01ug/ml). MTT assay was used to determine cell survival and proliferation rate at 48hours and 96hours. Four rabbits were used to study toxicity of etoposide To evaluate retinal toxicity, bilateral simultaneous electroretinograms (ERGs) were obtained. Five rabbits were used to further study the efficacy of etoposide against experimental PVR. Results: The slope of dose-response curve was slowly declined for etoposide, but very sharp for doxorubicin and daunorubicin in MTT assay. Etoposide was selected for further toxicity and efficacy tests. There was no significant change in b-wave amplitudes in etoposide (0.02 mg, 10μg/ml)-injected eyes after 2 weeks, but significant reduction in etoposide (0.2 mg, 100μg/ml)-injected eyes. Ten days after gas compression vitrectomy with 0.4 ml SF6, the right eyes of rabbits were injected with 1×105 cells of RPE and etoposide (0.02 mg/ 0.1 cc PBS) and the left eyes were injected with 1×105 cells of RPE and PBS 0.1cc. In the first 2 weeks, etoposide-injected eyes had statistically significant lower grading of PVR than the control eyes. Conclusions: These results demonstrated etoposide would be an adjunctive for the prevention of PVR. Further pharmacokinetic study of intravitreal injection of etoposide is necessary for repeated intravitreal administrations.
会议投稿录入:毛进    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2012
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备12035550号